- Home
- FENC vs LIEN Comparison
FENC vs LIEN Comparison
Compare FENC & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- LIEN
- Stock Information
- Founded
- FENC 1996
- LIEN 2021
- Country
- FENC United States
- LIEN United States
- Employees
- FENC 32
- LIEN N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- LIEN
- Sector
- FENC Health Care
- LIEN
- Exchange
- FENC Nasdaq
- LIEN NYSE
- Market Cap
- FENC 222.9M
- LIEN 234.6M
- IPO Year
- FENC 2001
- LIEN 2022
- Fundamental
- Price
- FENC $8.34
- LIEN $10.29
- Analyst Decision
- FENC Strong Buy
- LIEN Buy
- Analyst Count
- FENC 2
- LIEN 2
- Target Price
- FENC $13.00
- LIEN N/A
- AVG Volume (30 Days)
- FENC 83.2K
- LIEN 56.1K
- Earning Date
- FENC 08-12-2025
- LIEN 08-07-2025
- Dividend Yield
- FENC N/A
- LIEN 13.25%
- EPS Growth
- FENC N/A
- LIEN 30.25
- EPS
- FENC N/A
- LIEN 1.15
- Revenue
- FENC $30,912,000.00
- LIEN $30,828,508.00
- Revenue This Year
- FENC $0.85
- LIEN $154.46
- Revenue Next Year
- FENC $55.16
- LIEN $10.64
- P/E Ratio
- FENC N/A
- LIEN $8.90
- Revenue Growth
- FENC N/A
- LIEN 151.96
- 52 Week Low
- FENC $3.96
- LIEN $9.70
- 52 Week High
- FENC $8.72
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- FENC 58.31
- LIEN N/A
- Support Level
- FENC $7.53
- LIEN N/A
- Resistance Level
- FENC $8.68
- LIEN N/A
- Average True Range (ATR)
- FENC 0.49
- LIEN 0.00
- MACD
- FENC -0.04
- LIEN 0.00
- Stochastic Oscillator
- FENC 63.18
- LIEN 0.00
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.